Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: role of the cytoplasmic domain

J Virol. 1996 Apr;70(4):2669-73. doi: 10.1128/JVI.70.4.2669-2673.1996.

Abstract

Previous studies have shown that the glycoprotein cytoplasmic domains of human immunodeficiency virus type 2 (HIV-2) or simian immunodeficiency virus of macaques modulate biological activities of the viral glycoprotein complex, including syncytium formation, exterior glycoprotein conformation, and glycoprotein incorporation into budding virus particles. We have now utilized a recombinant expression system to study interactions of full-length or truncated HIV-2 glycoproteins with coexpressed HIV-2 Gag proteins which self-assemble and bud as virus-like particles. Interestingly, budding of HIV-2 virus-like particles from cells was enhanced 5- to 24-fold when Gag was coexpressed with the full-length HIV-2 glycoprotein, compared with Gag expressed either alone or with a truncated HIV-2 glycoprotein. The results obtained in this model system indicate that an additional effect of the lengthy cytoplasmic domain of the glycoprotein of HIV-2 is enhancement of particle budding. We speculate that the cytoplasmic domain of the viral glycoprotein of HIV-2 enhances budding by (i) potentiation of Gag structure or function or (ii) membrane modulation.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Base Sequence
  • Cell Line
  • Cloning, Molecular
  • DNA Primers
  • Gene Products, gag / genetics
  • Gene Products, gag / physiology
  • Glycoproteins / genetics
  • Glycoproteins / physiology*
  • HIV-2 / genetics
  • HIV-2 / physiology*
  • Humans
  • Molecular Sequence Data
  • Viral Proteins / genetics
  • Viral Proteins / physiology*
  • Virus Replication*

Substances

  • DNA Primers
  • Gene Products, gag
  • Glycoproteins
  • Viral Proteins